CALL (701) 339-8979TELEHEALTH CARE IN ALL 50 STATES • LICENSED PROVIDERS • ONGOING SUPPORT

PEPTIDE THERAPY / WEIGHT MANAGEMENT

Tirzepatide

A once-weekly dual GIP/GLP-1 medication for weight management and blood-sugar control.

STATUS
FDA-approved (brand-name) for type 2 diabetes, chronic weight management, and obstructive sleep apnea in adults with obesity. Compounded versions are not FDA-approved.
FORMS
Weekly injection
ACCESS
Prescription only · Telehealth in all 50 states

KEY TAKEAWAYS

  • Acts on two gut-hormone pathways: GIP and GLP-1
  • Produced some of the largest average weight reductions seen in medication trials
  • Prescribed alongside nutrition and activity support

01 / OVERVIEW

What it is

Tirzepatide is a single molecule that activates both the GIP and GLP-1 receptors — two hormones your body releases after meals. It is the first medication of its kind approved for weight management.

02 / MECHANISM

How it works

Like GLP-1 medications, tirzepatide reduces appetite, slows stomach emptying, and improves insulin response. Adding GIP activity appears to further improve how the body handles blood sugar and fat, which may contribute to its effect on weight.

04 / FIT

Who it may help

  • Adults with obesity, or overweight with a weight-related condition
  • People who have not reached their goals with lifestyle changes alone
  • Patients who may not have responded well to a GLP-1-only medication

05 / CAUTION

Who should avoid it

  • Personal or family history of medullary thyroid cancer or MEN2
  • Pregnancy, trying to conceive, or breastfeeding
  • History of pancreatitis (discuss with your provider)
  • Type 1 diabetes

06 / SAFETY

Possible side effects

  • Nausea, diarrhea, vomiting, constipation, or indigestion — usually mild to moderate and most common as doses increase
  • Decreased appetite and injection-site reactions
  • Less common but serious: pancreatitis, gallbladder problems, low blood sugar (with some diabetes medicines), kidney problems from dehydration
  • May reduce the effectiveness of oral birth control for a period after starting or dose changes — ask your provider

This is not a complete list. Your provider will review risks, benefits, and alternatives with you before starting any treatment.

QUESTIONS

Good to know.

Is tirzepatide better than semaglutide? +

In trials, average weight loss was higher with tirzepatide, but the right choice depends on your health history, how you tolerate the medication, and cost. Your provider will help you compare.

Can I switch from semaglutide? +

Often, yes. Your provider will review your current response and side effects before making a change.

Will I need follow-up visits? +

Yes. Regular check-ins let your provider adjust the plan, manage side effects, and track progress safely.

How do I get started? +

Complete a short Get Started form. A licensed provider in your state will review your goals and history by telehealth, order labs if needed, and decide whether Tirzepatide or another option is appropriate.

KEEP LEARNING

Related therapies.

VIEW THE FULL LIBRARY ↗
EDUCATIONAL INFORMATION

This page is for general education and is not medical advice. Tirzepatide requires a prescription and is provided only after evaluation by a licensed provider when appropriate. When a compounded formulation is prescribed, it is prepared by a licensed U.S. pharmacy for you specifically. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.